How will the EU life science strategy achieve competitiveness?

On Tuesday, 25 March, AmCham EU hosted a discussion on the EU’s forthcoming life sciences strategy and its role in enhancing the sector’s global competitiveness. Ann-Sofie Rönnlund, Member of Cabinet to Commissioner Zaharieva, outlined the Commission’s vision to promote innovation, resilience and patient access. Moderated by Felix Uedelhoven (GE Healthcare), Chair, Healthcare Committee, AmCham EU, the event explored how the EU can create a supportive regulatory and investment environment. Speakers stressed the importance of public-private collaboration and adequate public funding to boost research and innovation, positioning Europe as a global leader in health and ensuring long-term sustainability for patients, healthcare systems and businesses.